Distribution of systemically administered nanoparticles reveals a size-dependent effect immediately following cardiac ischaemia-reperfusion injury

David J. Lundy, Kun Hung Chen, Elsie K.W. Toh, Patrick C.H. Hsieh

Research output: Contribution to journalArticle

41 Citations (Scopus)


Nanoparticles represent an attractive option for systemic delivery of therapeutic compounds to the heart following myocardial infarction. However, it is well known that physicochemical properties of nanoparticles such as size, shape and surface modifications can vastly alter the distribution and uptake of injected nanoparticles. Therefore, we aimed to provide an examination of the rapid size-dependent uptake of fluorescent PEG-modified polystyrene nanoparticles administered immediately following cardiac ischaemia-reperfusion injury in mice. By assessing the biodistribution of nanoparticles with core diameters between 20 nm and 2 - 1/4m 30 minutes after their administration, we conclude that 20-200 nm diameter nanoparticles are optimal for passive targeting of the injured left ventricle.

Original languageEnglish
Article number25613
JournalScientific Reports
Publication statusPublished - May 10 2016
Externally publishedYes


ASJC Scopus subject areas

  • General

Cite this